Mesa Laboratories (MLAB) Invested Capital (2011 - 2025)

Mesa Laboratories has disclosed Invested Capital across 15 years of filings, most recently posting $186.7 million for Q4 2025.

• Invested Capital for Q4 2025 came in at $186.7 million, up 17.44% year-over-year; the trailing twelve-month figure through Dec 2025 was $186.7 million (up 17.44% YoY), and the FY2025 annual result was $163.6 million, up 12.51% from the prior year.
• Invested Capital came in at $186.7 million for Q4 2025 at Mesa Laboratories, up from $183.2 million in the prior quarter.
• In the past five years, Invested Capital ranged from a high of $406.5 million in Q1 2021 to a low of $145.4 million in Q1 2024.
• The 5-year median for Invested Capital is $383.8 million (2022), against an average of $306.8 million.
• Across the five-year window, Invested Capital soared 84.32% in 2021 and plunged 63.05% in 2024, its largest moves.
• Mesa Laboratories' Invested Capital stood at $396.3 million in 2021, then fell by 2.3% to $387.2 million in 2022, then increased by 4.07% to $403.0 million in 2023, then plunged by 60.55% to $159.0 million in 2024, then climbed by 17.44% to $186.7 million in 2025.
• The last three Invested Capital figures came in at $186.7 million (Q4 2025), $183.2 million (Q3 2025), and $176.7 million (Q2 2025), per Business Quant data.